Leicester Cough Questionnaire (LCQ) — Questions and Answers

Question 1: Which of the following is a conclusion drawn from the study about the LCQ?

It is not responsive to changes in cough severity.
It is only valid for use in COPD patients.
It is reliable but not valid for assessing the quality of life in patients with chronic cough.
It is a valid and reliable measure for evaluating cough-specific quality of life in patients with refractory or unexplained chronic cough. (Correct answer)

Correct answer: It is a valid and reliable measure for evaluating cough-specific quality of life in patients with refractory or unexplained chronic cough.

Explanation: The study concluded that the Leicester Cough Questionnaire (LCQ) is a valid and reliable measure for assessing cough-specific quality of life in patients with refractory or unexplained chronic cough. This suggests that the LCQ can effectively capture the impact of cough severity on the quality of life in this patient population, making it a valuable tool for clinical assessment and research in this context.

Question 2: Does the LCQ assess the frequency or severity of cough directly?

No — it assesses impact on quality of life, not cough frequency/severity (Correct answer)
Yes — it measures cough events per hour
No — it only measures sputum production
Yes — it uses a VAS for cough severity

Correct answer: No — it assesses impact on quality of life, not cough frequency/severity

The LCQ does not directly measure cough frequency or severity; it evaluates how cough impacts health-related quality of life across three domains.

Question 3: Compared to generic quality of life tools (e.g., SF-36), why is the LCQ preferred for chronic cough research?

Lower cost of administration
Shorter completion time
Greater sensitivity to cough-specific QoL changes (disease-specific tool) (Correct answer)
Better reliability scores

Correct answer: Greater sensitivity to cough-specific QoL changes (disease-specific tool)

Disease-specific tools like the LCQ are more sensitive to changes relevant to chronic cough than generic tools like the SF-36, which dilutes cough-specific effects with unrelated health domains.

Question 4: What challenge arises when using the LCQ in elderly patients with multiple comorbidities?

Difficulty attributing QoL impairment to cough alone versus other conditions (Correct answer)
The LCQ is too long for elderly patients
The 2-week recall period is too short for elderly patients
Elderly patients cannot use Likert scales

Correct answer: Difficulty attributing QoL impairment to cough alone versus other conditions

In elderly patients with multiple comorbidities, it can be difficult to determine whether LCQ score reductions are attributable to cough alone or confounded by other health conditions.

Question 5: The psychological domain of the LCQ was included because chronic cough is known to be associated with:

Improved immune function
Elevated mood and energy
Psychological distress including anxiety and depression (Correct answer)
No measurable mental health effects

Correct answer: Psychological distress including anxiety and depression

Chronic cough is strongly associated with psychological distress, including anxiety, depression, and embarrassment, which the LCQ psychological domain captures.

Question 6: Has the LCQ been validated for use in patients with COPD?

Only in COPD patients without cough
No — COPD patients require a different tool
Only in mild COPD
Yes — validated and widely used in COPD populations (Correct answer)

Correct answer: Yes — validated and widely used in COPD populations

The LCQ has been validated in COPD populations and is commonly used to assess the cough-specific quality of life burden in these patients alongside disease-specific COPD tools.

Question 7: To adequately power a clinical trial using the LCQ as the primary outcome measure, a researcher must know the:

Languages into which the LCQ has been formally translated
Number of LCQ items assigned to each domain
Year in which the LCQ was originally published
Expected MCID and the standard deviation of LCQ scores in the target population (Correct answer)

Correct answer: Expected MCID and the standard deviation of LCQ scores in the target population

Sample size calculations require both the expected clinically meaningful difference (MCID) and the variability of scores (SD) to determine adequate statistical power.

Question 8: Research has shown that the LCQ can differentiate between patients with refractory chronic cough and those with cough that responds to first-line treatment. This is called:

Content validity
Criterion validity
Convergent validity
Discriminant validity (Correct answer)

Correct answer: Discriminant validity

The ability of the LCQ to distinguish between clinically different patient groups (refractory vs. responsive cough) demonstrates discriminant validity.

Question 9: Has the LCQ been used in post-COVID chronic cough research?

Only in hospitalized COVID patients
No — post-COVID cough requires specialized tools
LCQ is not sensitive enough for post-COVID use
Yes — emerging research has applied LCQ to post-COVID cough patients (Correct answer)

Correct answer: Yes — emerging research has applied LCQ to post-COVID cough patients

Emerging research has applied the LCQ to assess cough-related quality of life in patients with post-COVID syndrome, given its responsiveness to chronic cough of various etiologies.

Question 10: Embarrassment caused by coughing in the presence of others is classified in the LCQ as:

A physical domain item
A psychological domain item (Correct answer)
Not included in the LCQ
A social domain item

Correct answer: A psychological domain item

Embarrassment from coughing in others' presence is an emotional/psychological response captured in the psychological domain.

Question 11: Which of the following is a key advantage of the LCQ's self-administered format in US clinical settings?

It requires no patient education about chronic cough
It allows real-time scoring by the clinician
It eliminates the need for patient literacy
Patients can complete it in the waiting room, saving clinician time (Correct answer)

Correct answer: Patients can complete it in the waiting room, saving clinician time

The self-administered format allows patients to complete the LCQ in waiting areas, efficiently integrating it into routine clinical workflows in the US.

Question 12: A patient scores 7 on every social domain item of the LCQ. This indicates:

Moderate social impairment
Severe social impairment from cough
No social impairment — they never experience cough-related social limitations (Correct answer)
The questionnaire was completed incorrectly

Correct answer: No social impairment — they never experience cough-related social limitations

A score of 7 on every social domain item means the patient never experiences cough-related social limitations, reflecting excellent social quality of life.

Question 13: In patients with chronic cough receiving speech pathology treatment (cough suppression therapy), what LCQ changes are expected?

LCQ is not sensitive to speech therapy outcomes
Worsened LCQ scores initially
Improved (higher) LCQ scores reflecting better QoL post-therapy (Correct answer)
No change in LCQ scores with speech therapy

Correct answer: Improved (higher) LCQ scores reflecting better QoL post-therapy

Studies of cough suppression therapy delivered by speech pathologists have demonstrated improved LCQ scores, validating the tool's responsiveness to this treatment approach.

Question 14: Why is the LCQ considered superior to generic quality of life tools such as the SF-36 for cough patients?

It is longer and more comprehensive
It was validated in larger samples than the SF-36
It uses a binary yes/no format, reducing patient burden
It is disease-specific, capturing cough-relevant impacts not measured by generic tools (Correct answer)

Correct answer: It is disease-specific, capturing cough-relevant impacts not measured by generic tools

Disease-specific tools like the LCQ capture cough-specific impacts with greater sensitivity to change than generic measures like the SF-36.

Question 15: In global chronic cough research, the LCQ has been translated into approximately how many languages?

It has only been used in English
More than 15 languages (Correct answer)
5–10 languages
Fewer than 5

Correct answer: More than 15 languages

The LCQ has been translated and cross-culturally adapted into more than 15 languages, enabling its use in international multicenter trials.

Question 16: What did a systematic review of chronic cough outcome measures conclude about the LCQ?

Only the physical domain of the LCQ meets validation standards
The LCQ is one of the most widely used and well-validated chronic cough QoL tools (Correct answer)
The LCQ should be replaced by newer tools
The LCQ lacks sufficient validation for routine use

Correct answer: The LCQ is one of the most widely used and well-validated chronic cough QoL tools

Systematic reviews of chronic cough outcome measures consistently identify the LCQ as among the best-validated and most widely used patient-reported outcome tools in the field.

Question 17: In patients with treatment-refractory chronic cough, LCQ scores are typically:

Variable based on the clinician's assessment
Persistently low, reflecting ongoing severe QoL impairment (Correct answer)
Higher than average due to disease acceptance
Normal because patients adapt over time

Correct answer: Persistently low, reflecting ongoing severe QoL impairment

Treatment-refractory chronic cough patients typically maintain persistently low LCQ scores, indicating sustained quality of life impairment despite treatment attempts.

Question 18: How long does it typically take for patients to complete the LCQ?

5 minutes (Correct answer)
10 minutes
3 minutes
1 minute

Correct answer: 5 minutes

Explanation: Patients typically take about 5 minutes to complete the Leicester Cough Questionnaire (LCQ). This brief duration makes it a convenient tool for assessing cough severity and its impact on quality of life in clinical settings.

Question 19: In studies evaluating speech pathology cough suppression therapy (CST), the LCQ demonstrated improvements primarily in:

All three domains — physical, psychological, and social (Correct answer)
Social domain only
Physical domain only
No domain, as CST does not affect quality of life

Correct answer: All three domains — physical, psychological, and social

Research on CST shows significant improvements across all three LCQ domains, reflecting the broad quality of life benefits of effective cough suppression.

Question 20: What was the primary finding of the original LCQ validation study?

The LCQ was only valid for COPD patients
The LCQ demonstrated good validity, reliability, and responsiveness in chronic cough patients (Correct answer)
The LCQ required further development before clinical use
The LCQ correlated poorly with objective cough counts

Correct answer: The LCQ demonstrated good validity, reliability, and responsiveness in chronic cough patients

The original 2003 validation study confirmed that the LCQ had good construct validity, internal consistency (Cronbach's alpha >0.90), and responsiveness to treatment change.

Question 21: How is the LCQ used in clinical drug trials for novel antitussive medications in the US?

Only as a safety monitoring tool
To confirm cough diagnoses for trial eligibility
As a primary or secondary patient-reported outcome endpoint (Correct answer)
To replace objective cough monitoring

Correct answer: As a primary or secondary patient-reported outcome endpoint

In US clinical trials for antitussive drugs, the LCQ serves as a primary or secondary patient-reported outcome endpoint measuring treatment effect on cough-related quality of life.

Question 22: The MCID of 1.3 points for the LCQ was established through which type of analysis?

Pharmacoeconomic modeling
Normative population data
Anchor-based analysis using patient global ratings of change (Correct answer)
Expert consensus only

Correct answer: Anchor-based analysis using patient global ratings of change

The LCQ MCID of approximately 1.3 points was determined through anchor-based analysis, where patient global impressions of change served as the external anchor.

Question 23: Is the LCQ validated for pediatric patients?

No — it was developed and validated for adults (Correct answer)
Yes, for children over 5 years old
Yes — it is the gold standard for children
Only for adolescents over 16

Correct answer: No — it was developed and validated for adults

The LCQ was developed and validated for use in adults; separate pediatric cough quality of life tools exist for children.

Question 24: A patient reports that they avoid social gatherings because of embarrassment from coughing. Which LCQ domain is most relevant?

Physical
Psychological
Social (Correct answer)
All three equally

Correct answer: Social

Avoidance of social gatherings due to cough-related embarrassment is captured primarily by the LCQ social domain.

Question 25: What does a Visual Analogue Scale (VAS) for cough measure that the LCQ does NOT?

Cough severity as perceived by the patient at a single point in time (Correct answer)
Long-term cough burden over 2 weeks
Quality of life across three domains
Social impacts of cough

Correct answer: Cough severity as perceived by the patient at a single point in time

A VAS for cough captures instantaneous patient-perceived severity, while the LCQ measures quality of life impact over the past 2 weeks across physical, psychological, and social domains.

Question 26: What is the primary purpose of establishing a baseline LCQ score?

To classify the patient's cough type
To confirm the diagnosis of chronic cough
To have a reference point for monitoring treatment-related quality of life changes (Correct answer)
To determine insurance reimbursement eligibility

Correct answer: To have a reference point for monitoring treatment-related quality of life changes

A baseline LCQ score provides the reference point against which subsequent scores are compared to assess whether treatment has produced meaningful quality of life improvement.

Question 27: The psychological domain of the LCQ contains how many items?

6
4
5 (Correct answer)
3

Correct answer: 5

The LCQ psychological domain contains 5 items addressing emotional consequences such as embarrassment, depression, anxiety, irritability, and feeling distressed.

Question 28: In which respiratory diseases has the LCQ been used as an outcome measure?

COPD, Cystic Fibrosis, and non-CF bronchiectasis (Correct answer)
Asthma only
Cystic Fibrosis only
COPD only

Correct answer: COPD, Cystic Fibrosis, and non-CF bronchiectasis

Explanation: The Leicester Cough Questionnaire (LCQ) has been utilized as an outcome measure in various respiratory diseases, including COPD (Chronic Obstructive Pulmonary Disease), Cystic Fibrosis, and non-CF bronchiectasis. It assesses the impact of cough severity across different conditions, making it a versatile tool for evaluating cough-related quality of life.

Question 29: Can the LCQ be used to assess chronic cough in patients with lung cancer?

No — cancer patients require oncology-specific tools only
Only in early-stage cancer
Yes — it has been applied in oncology settings to measure cough-related QoL (Correct answer)
Only postoperatively

Correct answer: Yes — it has been applied in oncology settings to measure cough-related QoL

The LCQ has been used in oncology settings to evaluate cough-related quality of life in lung cancer patients as a patient-reported outcome measure.

Question 30: Compared to the Cough Quality of Life Questionnaire (CQLQ), the LCQ is considered:

Equivalent in length and scope
Less validated and rarely used in research
Longer and less practical for routine clinical use
Shorter and more practical while retaining good psychometric properties (Correct answer)

Correct answer: Shorter and more practical while retaining good psychometric properties

The LCQ (19 items) is shorter than the CQLQ (28 items) while maintaining strong psychometric properties, making it more practical for clinical settings.

Question 31: Which clinical specialties most commonly administer the LCQ in the US?

Gastroenterology only
Pulmonology and respiratory medicine (Correct answer)
Dermatology and allergy
Orthopedics and sports medicine

Correct answer: Pulmonology and respiratory medicine

The LCQ is most commonly used in pulmonology and respiratory medicine clinics in the US, where chronic cough patients are routinely managed.

Question 32: Which research finding demonstrated the LCQ's ability to detect improvements after speech language pathology cough suppression therapy?

No change in LCQ scores with behavioral therapy
Only the physical domain improved after SLP therapy
LCQ worsened after SLP therapy
Significantly improved LCQ scores post-SLP therapy in RCTs (Correct answer)

Correct answer: Significantly improved LCQ scores post-SLP therapy in RCTs

Randomized controlled trials of speech language pathology cough suppression therapy have demonstrated significant LCQ score improvements, confirming the tool's responsiveness to behavioral interventions.

Question 33: How many domains does the LCQ use to calculate its total score?

Two domains
Four domains
Three domains (Correct answer)
Five domains

Correct answer: Three domains

The LCQ calculates scores across three domains: physical, psychological, and social.

Question 34: What characteristic of the LCQ allows it to detect responsiveness to treatment over time?

Its focus on objective lung function parameters
Its use of binary yes/no items
Its 7-point Likert scale providing sufficient response variance (Correct answer)
Its administration by trained nurses only

Correct answer: Its 7-point Likert scale providing sufficient response variance

The 7-point Likert scale on each item provides sufficient variance to detect clinically meaningful changes in response to treatment.

Question 35: How frequently should the LCQ be administered to monitor treatment response?

Only at the end of treatment
At each clinical visit or every 4–8 weeks during active treatment (Correct answer)
Once at diagnosis and never again
Daily during acute flares

Correct answer: At each clinical visit or every 4–8 weeks during active treatment

The LCQ should be administered at baseline and repeated at each clinical visit (or every 4–8 weeks) to track changes in quality of life during treatment.

Question 36: In LCQ validation studies, what criterion validity method is typically used?

Correlation with FEV1 values
Validation against chest X-ray findings
Correlation with other established cough QoL tools and objective cough counts (Correct answer)
Comparison against blood tests

Correct answer: Correlation with other established cough QoL tools and objective cough counts

Criterion validity of the LCQ is established by correlating its scores with other validated cough quality of life measures and objective cough frequency data.

Question 37: A meta-analysis of cough PROs would rank the LCQ's internal consistency (Cronbach's alpha) as:

Variable and unreliable across studies
Good to excellent (alpha > 0.70) (Correct answer)
Acceptable (alpha 0.60–0.69)
Poor (alpha < 0.60)

Correct answer: Good to excellent (alpha > 0.70)

The LCQ consistently demonstrates good to excellent internal consistency with Cronbach's alpha values typically above 0.70 across multiple studies.

Question 38: What measure was used to define a stable population for test-retest reliability assessment?

Change in forced expiratory volume in 1 second (FEV1)
Change in cough severity visual analogue scale (VAS)
Change in sputum volume
Patient global impression of change (PGIC) (Correct answer)

Correct answer: Patient global impression of change (PGIC)

Explanation: In the study, the measure used to define a stable population for test-retest reliability assessment was the Patient Global Impression of Change (PGIC). This measure allows patients to subjectively rate their overall change in symptoms over time. A stable population based on PGIC indicates individuals who perceive minimal change in their condition, providing a suitable group for evaluating the reliability of the LCQ over time.

Question 39: Compared to the physical domain, the social domain of the LCQ tends to show which pattern in patients with well-controlled chronic cough?

Worse scores even when physical symptoms are controlled
Worsening due to increased awareness of social situations
No change regardless of treatment
Proportional improvement alongside physical domain (Correct answer)

Correct answer: Proportional improvement alongside physical domain

When chronic cough is well controlled, social domain scores typically improve alongside physical scores, as reduced coughing restores social participation.

Question 40: The LCQ social domain specifically covers which of the following areas?

Nutritional intake
Medication adherence
Hospital visit frequency
Disruption to social activities and relationships (Correct answer)

Correct answer: Disruption to social activities and relationships

The LCQ social domain covers disruptions to social activities, interactions, and relationships caused by chronic cough.

Question 41: The development of the LCQ was motivated in part by the lack of:

Validated patient-reported outcome measures specific to chronic cough (Correct answer)
Spirometry protocols for cough assessment
Imaging tools for cough diagnosis
Pharmacological treatments for cough

Correct answer: Validated patient-reported outcome measures specific to chronic cough

At the time of its development, there were no validated chronic-cough-specific patient-reported outcome measures, which the LCQ was created to address.

Question 42: Why is it important to assess both the physical and psychological domains of the LCQ in clinical practice?

Because physical and psychological impairments are always identical in severity
Because some patients have significant psychological burden despite mild physical symptoms, requiring different management (Correct answer)
Because the physical domain cannot be scored independently
Because regulators require both scores for drug approval

Correct answer: Because some patients have significant psychological burden despite mild physical symptoms, requiring different management

Some patients have disproportionate psychological distress relative to physical symptom burden, which requires targeted psychological intervention rather than purely medical treatment.

Question 43: Throat clearing is included in the LCQ physical domain because it is considered:

A psychological coping behavior
A direct physical manifestation related to chronic cough (Correct answer)
An occupational hazard
A social adaptive behavior

Correct answer: A direct physical manifestation related to chronic cough

Throat clearing is a physical symptom commonly associated with chronic cough and is captured in the physical domain.

Question 44: How does the LCQ relate to the Cough Hypersensitivity Questionnaire (CHQ)?

They are interchangeable
They measure identical constructs
The CHQ replaces the LCQ in modern practice
The CHQ measures hypersensitivity symptoms while LCQ measures QoL — they are complementary (Correct answer)

Correct answer: The CHQ measures hypersensitivity symptoms while LCQ measures QoL — they are complementary

The CHQ was designed to measure cough hypersensitivity symptoms (throat sensations, urge to cough), complementing the LCQ's quality of life focus in comprehensive cough assessment.

Question 45: Which theoretical framework most closely guided the domain structure of the LCQ?

Behavioral activation theory
Cognitive dissonance model
Gate control theory of pain
Biopsychosocial model of health (Correct answer)

Correct answer: Biopsychosocial model of health

The LCQ's three-domain structure (physical, psychological, social) reflects the biopsychosocial model, capturing multidimensional cough impact.

Question 46: Which journal first published the original LCQ validation study?

Thorax
European Respiratory Journal (Correct answer)
Lancet
American Journal of Respiratory and Critical Care Medicine

Correct answer: European Respiratory Journal

The original LCQ validation study was published in the European Respiratory Journal in 2003.

Question 47: What type of patients was the LCQ originally developed and validated in?

Post-surgical patients
Pediatric asthma patients
Acute upper respiratory infection patients
Patients with chronic cough (Correct answer)

Correct answer: Patients with chronic cough

The LCQ was developed specifically for adults with chronic cough to measure the health-related quality of life impact.

Question 48: In patients with idiopathic chronic cough (ICC), what LCQ scores are typically observed?

Markedly reduced scores indicating significant quality of life impairment (Correct answer)
Scores only reduced in the physical domain
No reliable data exists for ICC patients
Normal scores indistinguishable from healthy controls

Correct answer: Markedly reduced scores indicating significant quality of life impairment

Patients with idiopathic chronic cough typically demonstrate markedly reduced LCQ scores across all three domains, reflecting profound quality of life impairment.

Question 49: What did studies of the LCQ in clinical trials of gefapixant (P2X3 antagonist) demonstrate?

Significant LCQ score improvements correlating with reduced cough frequency (Correct answer)
No change in LCQ scores with gefapixant
LCQ could not detect drug-related changes
LCQ was not used in gefapixant trials

Correct answer: Significant LCQ score improvements correlating with reduced cough frequency

Clinical trials of gefapixant demonstrated significant improvements in LCQ scores alongside reductions in cough frequency, further validating the LCQ's responsiveness to pharmacotherapy.

Question 50: Which approach is commonly used to estimate the LCQ MCID using an anchor-based method?

Using ROC curve analysis comparing LCQ with chest X-ray findings
Correlating LCQ score change with a Patient Global Impression of Change (PGIC) rating (Correct answer)
Comparing LCQ scores with spirometry FEV1 values
Calculating Cronbach's alpha before and after treatment

Correct answer: Correlating LCQ score change with a Patient Global Impression of Change (PGIC) rating

The anchor-based method links LCQ score change to a patient-rated external anchor such as the Patient Global Impression of Change, grounding the MCID in patient perception.

Question 51: How has the LCQ been used in patients with chronic cough secondary to gastroesophageal reflux (GERD)?

To replace pH monitoring
To measure acid reflux frequency
To monitor quality of life changes as reflux treatment is adjusted (Correct answer)
To diagnose GERD-related cough

Correct answer: To monitor quality of life changes as reflux treatment is adjusted

In GERD-related cough, the LCQ is used as an outcome measure to track quality of life improvement as anti-reflux therapy is optimized.

Question 52: In a systematic review context, the LCQ is considered a preferred outcome measure for chronic cough trials because:

It is the only available cough quality of life tool
It requires no patient training to complete
It has the strongest evidence base for reliability, validity, and responsiveness among cough-specific PROs (Correct answer)
It was endorsed by the FDA as the only acceptable endpoint

Correct answer: It has the strongest evidence base for reliability, validity, and responsiveness among cough-specific PROs

The LCQ has the most extensive evidence base for psychometric quality among chronic cough-specific PROs, making it the preferred measure in systematic reviews and meta-analyses.

Question 53: Can the LCQ be used in patients with asthma-related chronic cough?

Only if combined with spirometry
No — asthma requires the ACQ instead
Yes — it has been applied in asthmatic patients with chronic cough (Correct answer)
Only in non-allergic asthma

Correct answer: Yes — it has been applied in asthmatic patients with chronic cough

The LCQ is applicable to asthma patients with chronic cough, capturing cough-related quality of life impacts independent of the underlying diagnosis.

Question 54: A higher LCQ domain score indicates:

Greater cough frequency
More severe symptoms
Greater healthcare utilization
Better health-related quality of life (Correct answer)

Correct answer: Better health-related quality of life

Higher LCQ scores indicate better health-related quality of life, as the scale is anchored so that 7 = never impaired.

Question 55: What normative LCQ data exists for healthy (non-coughing) adults?

Extensive normative data is widely published
Limited normative data exists, making interpretation relative to clinical change rather than population norms (Correct answer)
No normative studies have been conducted
Normative data shows a mean of 15 for healthy adults

Correct answer: Limited normative data exists, making interpretation relative to clinical change rather than population norms

Normative LCQ data for healthy adults is limited; clinical interpretation therefore relies on within-patient change scores and established MCIDs rather than comparison to population norms.

Question 56: Which of the following best describes the utility of the LCQ in clinical trials?

It provides a standardized measure to evaluate treatment outcomes. (Correct answer)
It serves as a diagnostic tool for identifying respiratory diseases.
It helps assess the efficacy of cough suppressants.
It monitors changes in lung function over time.

Correct answer: It provides a standardized measure to evaluate treatment outcomes.

Explanation: In clinical trials, the Leicester Cough Questionnaire (LCQ) serves as a valuable tool for evaluating treatment outcomes. It provides a standardized measure specifically designed to assess the impact of cough on patients' quality of life. By administering the LCQ before and after interventions, researchers can quantitatively evaluate the effectiveness of treatments in reducing cough severity and improving patients' overall well-being. This standardized approach allows for objective comparisons across different treatment groups and enables researchers to draw meaningful conclusions about the efficacy of interventions in managing chronic cough. While the LCQ does not serve as a diagnostic tool for identifying respiratory diseases or monitoring changes in lung function, its primary utility in clinical trials lies in its ability to assess treatment outcomes and measure the impact of interventions on patients' quality of life.

Question 57: For patients with upper airway cough syndrome (UACS), how is the LCQ typically applied?

To replace nasal endoscopy
To measure QoL at baseline and after treatment of the underlying cause (Correct answer)
To determine antibiotic treatment duration
To diagnose UACS

Correct answer: To measure QoL at baseline and after treatment of the underlying cause

In UACS (formerly post-nasal drip syndrome), the LCQ measures quality of life impairment at baseline and monitors improvement as nasal pathology is treated.

Question 58: According to the study, what improvement in the LCQ total score was considered clinically meaningful?

≥ 1.3 points (Correct answer)
≥ 0.5 points
≥ 2.0 points
≥ 3.5 points

Correct answer: ≥ 1.3 points

Explanation: The study suggests that a mean improvement ranging from 1.3 to 2.3 points for the LCQ total score was considered clinically meaningful. This improvement in score indicates a significant positive change in the impact of cough severity on the quality of life of patients.

Question 59: What has research shown about the correlation between LCQ scores and objective cough frequency?

Perfect correlation (r=1.0)
Modest-to-moderate correlation, indicating they measure related but distinct constructs (Correct answer)
Strong inverse correlation
No significant correlation

Correct answer: Modest-to-moderate correlation, indicating they measure related but distinct constructs

Research shows a modest-to-moderate correlation between LCQ scores and objective cough frequency, confirming that subjective QoL impact and objective frequency are related but not identical.

Question 60: In the context of the LCQ, which of the following best describes the term "cross-sectional validity"?

The ability of the LCQ to distinguish between patients with different severities of chronic cough at one point in time (Correct answer)
The ability of the LCQ to be administered to patients of different age groups
The ability of the LCQ to measure changes over time
The ability of the LCQ to be used in different languages

Correct answer: The ability of the LCQ to distinguish between patients with different severities of chronic cough at one point in time

Explanation: Cross-sectional validity refers to the ability of an instrument, such as the LCQ, to accurately differentiate between individuals with varying levels of the condition being measured (in this case, chronic cough severity) at a single point in time. It assesses how well the questionnaire captures the differences in severity among patients when administered once.

Leicester Cough Questionnaire (LCQ)

The Leicester Cough Questionnaire (LCQ) is a validated 19-item self-reported health-related quality-of-life instrument used in clinical research and pulmonology practice to assess the impact of chronic cough across physical, psychological, and social domains. This knowledge assessment tests proficiency in LCQ structure, scoring methodology, clinical application, and comparative research.

Questions

75 min

Time Limit

70%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds